Bicocca Open Archive

Logo unimib boa
LOCATELLI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.601
AS - Asia 7.402
EU - Europa 5.936
SA - Sud America 969
Continente sconosciuto - Info sul continente non disponibili 447
AF - Africa 156
OC - Oceania 19
Totale 29.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.960
SG - Singapore 2.297
CN - Cina 1.614
IT - Italia 1.511
VN - Vietnam 1.437
HK - Hong Kong 906
DE - Germania 828
RU - Federazione Russa 805
BR - Brasile 718
CA - Canada 539
SE - Svezia 533
IE - Irlanda 520
UA - Ucraina 502
GB - Regno Unito 354
IN - India 238
FR - Francia 223
FI - Finlandia 174
BD - Bangladesh 142
AT - Austria 121
KR - Corea 118
ID - Indonesia 98
TR - Turchia 96
AR - Argentina 84
IQ - Iraq 82
NL - Olanda 64
DK - Danimarca 54
PL - Polonia 53
CO - Colombia 52
ZA - Sudafrica 51
MX - Messico 49
SA - Arabia Saudita 48
PK - Pakistan 46
BE - Belgio 44
EC - Ecuador 41
JP - Giappone 40
PH - Filippine 36
ES - Italia 35
CH - Svizzera 30
MY - Malesia 28
UZ - Uzbekistan 25
BG - Bulgaria 22
NP - Nepal 20
CL - Cile 18
VE - Venezuela 18
KE - Kenya 17
MA - Marocco 17
TN - Tunisia 17
AU - Australia 16
CR - Costa Rica 15
JM - Giamaica 13
LB - Libano 13
PY - Paraguay 13
TW - Taiwan 13
EG - Egitto 12
PE - Perù 12
EU - Europa 11
OM - Oman 11
CZ - Repubblica Ceca 10
AL - Albania 9
AZ - Azerbaigian 9
IL - Israele 9
IR - Iran 9
KZ - Kazakistan 9
PS - Palestinian Territory 9
TH - Thailandia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 8
HN - Honduras 8
JO - Giordania 8
EE - Estonia 7
KG - Kirghizistan 7
RO - Romania 7
GT - Guatemala 6
DZ - Algeria 5
PT - Portogallo 5
AO - Angola 4
BO - Bolivia 4
HR - Croazia 4
LT - Lituania 4
RS - Serbia 4
SC - Seychelles 4
BY - Bielorussia 3
HU - Ungheria 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SN - Senegal 3
BH - Bahrain 2
CD - Congo 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ML - Mali 2
MR - Mauritania 2
MU - Mauritius 2
Totale 29.072
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Singapore 1.323
Ashburn 1.282
Woodbridge 1.090
Fairfield 979
Hong Kong 895
Houston 798
Chandler 736
Wilmington 721
San Jose 690
Frankfurt am Main 562
Jacksonville 506
Dublin 497
Milan 450
Seattle 450
Ho Chi Minh City 439
Hanoi 350
Dearborn 323
Toronto 322
Beijing 312
Cambridge 310
New York 298
Santa Clara 227
Chicago 220
Princeton 213
Council Bluffs 211
Los Angeles 201
Hefei 179
Dallas 156
The Dalles 141
Nanjing 136
Seoul 108
Vienna 106
Lauterbourg 100
Rome 92
Lawrence 87
Altamura 86
Shanghai 83
Boardman 82
Lachine 82
Moscow 79
Buffalo 76
Jakarta 74
São Paulo 67
Helsinki 65
Da Nang 63
Guangzhou 53
Haiphong 53
London 53
Detroit 49
Brussels 41
Nanchang 41
San Diego 41
Falls Church 40
Baghdad 37
Columbus 37
Munich 36
Orem 33
Hebei 32
Warsaw 30
Andover 29
Nuremberg 29
Tokyo 29
Atlanta 27
Biên Hòa 27
Changsha 27
Denver 27
Kent 27
San Francisco 27
Shenyang 27
Mountain View 26
Rio de Janeiro 26
Tianjin 26
Brooklyn 25
Phoenix 25
Pune 25
Ha Long 24
Huizen 24
Philadelphia 24
Elora 23
Fremont 23
Bologna 22
Tashkent 22
Salt Lake City 21
Grafing 20
Hải Dương 20
Jiaxing 20
Ottawa 20
Riyadh 20
Can Tho 19
Dhaka 19
Jinan 19
Renton 19
Stockholm 19
Turin 19
Turku 19
Poplar 18
Boston 17
Hangzhou 17
Jeddah 17
Totale 19.362
Salva come PNG Salva come JPEG
Nome #
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 512
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 464
Growth hormone secretagogues and the regulation of calcium signaling in muscle 458
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 455
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 404
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 398
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 396
Neurotrophic and neuroregenerative effects of GH/IGF1 396
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 382
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 360
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 350
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 347
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 344
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 335
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 328
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 328
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 313
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 312
Feeding behavior during long-term hexarelin administration in young and old rats 310
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 308
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 306
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 302
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 300
Ghrelin in gastroenteric pathophysiology 297
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 296
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 290
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 289
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 289
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 285
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 285
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 285
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 283
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 283
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 281
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 279
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 277
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 277
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 275
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 272
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 265
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 263
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 261
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 260
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 258
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 255
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 254
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 254
La valutazione delle attività di tirocinio pratico da parte dei tutori 254
Somatotropic dysregulation in old mammals 253
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 252
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 250
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 250
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 250
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 249
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 249
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 247
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 241
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 237
Growth hormone-inhibiting activity of cortistatin in the rat 236
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 235
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 234
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 231
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 230
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 229
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 229
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 229
Low dose of insulin for assessment of growth hormone and cortisol release in short children 225
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 225
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 224
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 224
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 223
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 222
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 221
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 221
Ghrelin expression in gut endocrine growths 220
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 220
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 218
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 217
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 216
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 216
Pyruvate and satiety: can we fool the brain? 215
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 213
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 213
La somatopausa: nuove prospettive terapeutiche 210
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 208
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 208
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 208
Growth hormone-independent cardioprotective effects of hexarelin in the rat 206
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 206
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 205
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 202
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 201
Testosterone a key factor in gender related metabolic syndrome 199
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 198
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action 198
New active series of growth hormone secretagogues 198
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 196
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 189
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 187
Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat 187
Totale 26.745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.027 0 0 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20253.743 215 352 234 239 349 161 271 223 257 519 281 642
2025/202610.129 1.467 815 695 968 984 506 1.350 464 875 775 619 611
2026/2027619 242 352 25 0 0 0 0 0 0 0 0 0
Totale 29.530